Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys

Infection and Immunity

Volumn 66, Issue 6, 1998, Pages 2691-2697

  Giambartolomei, Guillermo H ^a   Dennis, Vida A ^a   Philipp, Mario T ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CELL STIMULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYME DISEASE; MEDIATOR RELEASE; MONONUCLEAR CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RHESUS MONKEY; SPIROCHETE;

BORRELIA BURGDORFERI;

EID: 0031841085     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.6.2691-2697.1998     Document Type: Article

References (49)

1. Harbour, A. G., W. Burgdorfer, E. Grunwaldt, and A. C. Steere. 1983. Antibodies of patients with Lyme disease to components of the Ixodes dam7 mini spirochete. J. Clin. Invest. 72:504-515.
2. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peeples. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139:263-273.
3. Benveniste, O., B. Vaslin, F. Villinger, R. LeGrand, A. A. Ansari, and D. Dormont. 1996. Cytokine mRNA levels in unmanipulated (ex vivo) and in vitro stimulated monkey PBMCs using a semi-quantitative RT-PCR and high sensitivity fluorescence-based detection strategy. Cytokine 8:32-41.
4. Brown, C., and S. L. Reiner. 1996. Prevention of experimental Lyme arthritis by blocking nitric oxide induction with aminoguanidine. FASKB J. 10:A1345.
5. Chiao, J. W., C. Pavia, M. Riley, W. Altmann-Lasekan, M. Abolhassani, K. Liegner, and A. Mittelman. 1994. Antigens of the Lyme disease spirochete Borrelia burgdorferi inhibit antigen or mitogen-induced lymphocyte proliferation. FEMS Immunol. Med. Microbiol. 8:151-155.
6. Cinco, M., R. Murgia, S. Perticarari, and G. Presani. 1994. Simultaneous measurement by flow cytometry of phagocytosis and metabolic burst induced in phagocytic cells in whole blood by Borrelia burgdorferi. FEMS Microbiol. Lett. 122:187-193.
7. Cox, D. L., D. R. Akins, K. W. Bourell, P. Lahdenne, M. V. Norgard, and J. D. Radolf. 1996. Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins. Proc. Natl. Acad. Sci. USA 93:7973-7978.
8. Dattwyler, R. J., J. A. Thomas, J. L. Benach, and M. G. Golightly. 1986. Cellular immune responses in Lyme disease. Zentbl. Bakteriol. Mikrobiol. Hyg. A 263:151-159.
9. Defosse, D. L., and R. C. Johnson. 1992. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect. Immun. 60:1109-1113.
10. Dennis, V. A., M. K. Aydintug, B. L. Lasater, A. L. Alvarez, and M. T. Philipp. Antigen-specific immune unresponsiveness of peripheral blood mononuclear cells during infection with Borrelia burgdorferi: a longitudinal study in the rhesus monkey. Submitted for publication.
11. de Silva, A. M., S. R. Telford III, L. R. Brunet, S. W. Barthold, and E. Fikrig. 1996. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183:271-275.
12. DeWaal Malefyt, R., J. Haanen, H. Spits, M. G. Roncolo, A. TeVelde, C. Fidgor, K. Johnson, R. Kastelein, H. Yssel, and J. E. DeVries. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocyles via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
13. Ding, L., P. S. Linsley, L. Y. Huang, R. N. Germain, and E. M. Shevach. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the upregulation of B7 expression. J. Immunol. 151:1224-1234.
14. Dunn, J. J., B. N. Lade, and A. G. Harbour. 1990. Outer surface protein A (OspA) from the Lyme disease spirochete, Borrelia burgdorferi: high level expression and purification of a soluble recombinant form of OspA. Protein Expr. Purif. 1:159-168.
15. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. O'Garra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451.
16. Giambartolomei, G. H., V. A. Dennis, B. L. Lasater, and M. T. Philipp. Unpublished data.
17. Golightly, M., J. Thomas, D. Volkman, and R. Dattwyler. 1988. Modulation of natural killer cell activity by Borrelia burgdorferi. Ann. N. Y. Acad. Sci. 539:103-109.
18. Habicht, G. S., L. I. Katona, and J. L. Benach. 1991. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J. Infect. Dis. 164:568-574.
19. Hauschildt, S., P. Hoffmann, H. U. Beuscher, G. Dufhues, P. Heinrich, K. H. Wiesmuller, G. Jung, and W. G. Bessler. 1990. Activation of bone marrowderived mouse macrophages by bacterial lipopeptide: cytokine production, phagocytosis and Ia expression. Eur. J. Immunol. 20:63-68.
20. Honarvar, N., U. E. Schaible, C. Galanos, R. Wallich, and M. M. Simon. 1994. A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies. Immunology 82:389-396.
21. Hughes, C. A., S. M. Engstrom, L. A. Coleman, C. B. Kodner, and R. C. Johnson. 1993. Protective immunity is induced by a Borrelia burgdorferi mutant that lacks OspA and OspB. Infect. Immun. 61:5115-5122..
22. Keane-Myers, A., and S. P. Nickell. 1995. T cell subset-dependent modulation of immunity to Borrelia burgdorferi infection in mice. J. Immunol. 154: 1770-1776.
23. Kenefiek, K. B., L. C. L. Lim, J. D. Alder, J. L. Schmitz, C. J. Czuprynski, and R. F. Schell. 1993. Induction of interleukin-1 release by high- and low-passage isolates of Borrelia burgdorferi. J. Infect. Dis. 167:1086-1092.
24. Krause, A., G. R. Burmester, A. Rensing, C. Schoerner, U. E. Schaible, M. M. Simon, P. Herzer, M. D. Kramer, and R. Wallich. 1992. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. J. Clin. Invest. 90:1077-1084.
25. Lee, E. H., and Y. Rikihisa. 1996. Absence of tumor necrosis factor alpha, interleukin-6 (IL-6), and granulocyte-macrophagc colony-stimulating factor expression but presence of IL-1β, IL-8, and IL-10 expression in human monocytes exposed to viable or killed Ehrlichia chaffeensis. Infect. Immun. 64:4211-4219.
26. Ma, Y., A. Sturrok, and J. J. Weis. 1991. Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect. Immun. 59:671-678.
27. Ma, Y., K. P. Seiler, K. Tai, L. Yang, M. Woods, and J. J. Weis. 1994. Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway. Infect. Immun. 62:3663-3671.
28. Ma, Y., and J. J. Weis. 1993. Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect. Immun. 61:3843-3853.
29. Modolell, M., U. E. Schaible, M. Rittig, and M. M. Simon. 1994. Killing of Borrelia burgdorferi by macrophages is dependent on oxygen radicals and nitric oxide and can be enhanced by antibodies to outer surface proteins of the spirochete. Immunol. Lett. 40:139-146.
30. Moffat, C. M., L. H. Sigal, A. C. Steere, D. A. Freeman, and J. M. Dwyer. 1984. Cellular immune findings in Lyme disease: correlation with serum IgM and disease activity. Am. J. Med. 77:625-632.
31. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818.
32. Nocton, J. J., F. Dressler, B. J. Rutledge, P. N. Rys, D. H. Persing, and A. C. Steere. 1994. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330:229-234.
33. Philipp, M. T., M. K. Aydintug, R. P. Bohm, Jr., F. B. Cogswell, V. A. Dennis, H. N. Lanners, R. C. Lowrie, Jr., E. D. Roberts, M. D. Conway, M. Karaçorlu, G. A. Peyman, D. J. Gubler, B. J. B. Johnson, J. Piesman, and Y. Gu. 1993. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect. Immun. 61:3047-3059.
34. Pohl-Koppe, A., K. Balachov, E. L. Logigian, A. C. Steere, and D. A. Hafler. 1996. The immune response to Borrelia burgdorferi (BB) is characterized by T-cell lines secreting both IFN-γ and IL-10 in patients with Lyme disease. FASEB J. 10:A1184.
35. Radolf, J. D., L. L. Arndt, D. R. Akins, L. L. Curetty, M. E. Levi, Y. Shen, L. S. Davis, and M. V. Norgard. 1995. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytes/macrophages. J. Immunol. 154:2866-2877.
36. Roberts, E. D., R. P. Bohm, Jr., F. B. Cogswell, H. N. Lanners, R. C. Lowrie, Jr., L. Povinelli, J. Piesman, and M. T. Philipp. 1995. Chronic Lyme disease in the rhesus monkey. Lab. Investig. 72:146-160.
37. Sigal, L. H., A. C. Steere, D. H. Freeman, and J. M. Dwyer. 1986. Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in bood. Arthritis Rheum. 29:761-769.
38. Sigal, L. H. 1989. Lyme disease, 1988. Immunologic manifestation and possible immunopathogenetic mechanisms. Semin. Arthritis Rheum. 18:153-167.
39. Tai, K.-F., Y. Ma, and J. J. Weis. 1994. Normal human B lymphocytes and mononuclear cells respond to the mitogenic and cytokine-stimulatory activities of Borrelia burgdorferi and its lipoprotein OspA. Infect. Immun. 62:520-528.
40. Tatro, J. B., L. I. Romero, D. Beasley, A. C. Steere, and S. Reichlin. 1994. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and interleukin-6 production in cultured rat brain cells. J. Infect. Dis. 169:1014-1022.
41. Vecchiarelli, A., C. Retini, C. Monari, C. Tascini, F. Bistoni, and T. R. Kozel. 1996. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun. 64:2846-2849.
42. Villinger, F., D. Hunt, A. Mayne, M. Vuchetich, H. Findley, and A. A. Ansari. 1993. Qualitative and quantitative studies of cytokines synthesized and secreted bv non-human primate peripheral blood mononuclear cells. Cytokine 5:469-479.
43. Villinger, F., S. S. Brar, A. Mayne, N. Chikkala, and A. A. Ansari. 1995. Comparative sequence analysis of cytokine genes from human and nonhuman primates. J. Immunol. 155:3946-3954.
44. Weis, J. J., Y. Ma, and L. F. Erdile. 1994. Biological activities of native and recombinant Borrelia burgdorferi outer surface protein A: dependence on lipid modification. Infect. Immun. 62:4632-4636.
45. Whitmire, W. M., and C. F. Garon. 1994. Induction of B-cell mitogenesis by outer surface protein C of Borrelia burgdorferi. 1994. J. Spirochetal TickBorne Dis. 1:64-68.
46. Wilske, B., U. Busch, V. Fingerle, S. Jauris-Heipke, V. Preac Mursic, D. Rossler, and G. Will. 1996. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection 24:208-212.
47. Yang, L., J. H. Weis, E. Eichwald, C. P. Kolbert, D. H. Persing, and J. J. Weis. 1994. Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect. Immun. 62:492-500.
48. Yin, Z., J. Braun, L. Neure, P. Wu, U. Eggens, A. Krause, T. Kamradt, and J. Sieper. 1997. T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines. Arthritis Rheum. 40:69-79.
49. Zhang, J. R., J. M. Hardham, A. G. Barbour, and S. J. Norris. 1997. Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275-285.